This study indicates that screening for anti-HMGCR autoantibodies in patients with suspected IIM is justified and could be helpful in the diagnostic workup not only in individuals with previous statin exposure. This evidence concerns the gene HMGCR and acquired idiopathic inflammatory myopathy.